Top

Lilie L. Lin, MD, FASTRO

Department of Radiation Oncology, Division of Radiation Oncology

Present Title & Affiliation

Primary Appointment

Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2001	Washington University, St. Louis, Missouri, US, MD
1997	Washington University, St. Louis, Missouri, US, Biochemistry, BA

Postgraduate Training

2002-2006	Clinical Residency, Radiation Oncology, Washington University, St. Louis, Missouri
2001-2002	Clinical Internship, Internal Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts

Board Certifications

2007	American Board of Radiology

Experience & Service

Academic Appointments

Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2021

Associate Professor, Department of Radiation Oncology, The Hospital of University of Pennsylvania, Philadelphia, PA, 2015 - 2017

Assistant Professor, Department of Radiation Oncology, The Hospital of University of Pennsylvania, Philadelphia, PA, 2006 - 2015

Administrative Appointments/Responsibilities

Associate Medical Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

Institutional Committee Activities

Member, Faculty Search Committee for tenure track, Professor, Department of Cancer Systems Imaging, 2019 - Present

Member, Faculty Search Committee for tenure track, Assistant/Associate Professor, Department of Radiation Oncology, 2018 - 2021

Member, Faculty Search Committee, Chief of Physics, Radiation Oncology Department, 2016 - 2016

Member, Radioactive Drug Research Committee, University of Pennsylvania, 2012 - 2017

Member, Medical Imaging Steering Committee, University of Pennsylvania, 2012 - 2015

Member, Radiation Oncology Clinical Protocol Review Committee, University of Pennsylvania Department of Radiation Oncology, 2012 - 2016

Member, Faculty Search Committee, Division of Nuclear Medicine, 2012 - 2013

Member, Bio-informatics Committee, Department of Radiation Oncology, University of Pennsylvania, 2008 - 2010

Member, Clinical Effectiveness and Quality Improvement (CEQI) Committee, Department of Radiation Oncology, University of Pennsylvania, 2008 - 2009

Member, Clinical Proton Protocol, Department of Radiation Oncology, University of Pennsylvania, 2007 - 2012

Member, Data Safety Monitoring, University of Pennsylvania, 2007 - 2010

Member, Faculty Search Committee, Division of Radiation Oncology, University of Pennsylvania, 2007 - 2013

Member, Clinical Research Infrastructure, Department of Radiation Oncology, University of Pennsylvania, 2007 - 2008

Member, Gender Equity Council, University of Pennsylvania, 2006 - 2008

Member, Quality Assurance (QA), Department of Radiation Oncology, University of Pennsylvania, 2006 - 2009

Honors & Awards

	Fellow, National Comprehensive Cancer Network Oncology
	Travel Award, National Cancer Institute and the Radiation Oncology Sciences Program Young Investigators Workshop
	Travel Award, National Cancer Institute and Radiation Oncology
	Research Fellow, ASCO/AACR Workshop: Methods in Clinical Cancer
	ACRO Resident Travel Award
	Advanced Course in Grant Writing, RSNA Chicago
	AAMC Early Career Professional Development Seminar, Washington DC
	RSNA Clinical Trials Methodology Workshop, Scottsdale, Arizona
	Young Doctor's Travel Award, International Gynecologic Cancer Society
	Ruby E. Rutherford Distinguished Professorship, The University of Texas MD Anderson Cancer Center

Selected Publications

Peer-Reviewed Articles

Weeks JK, Pantel AR, Gitto SB, Liu F, Schubert EK, Pryma DA, Farwell MD, Mankoff DA, Mach RH, Simpkins F, Lin LL. [(18)F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [(18)F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status. J Nucl Med 66(1):34-39, 2025. PMID: 39638432.
Seo A, Xiao W, Gjyshi O, Yoshida-Court K, Wei P, Swanson D, Cisneros Napravnik T, Grippin A, Venkatesan AM, Jacobsen MC, Fuentes DT, Lynn E, Sammouri J, Jhingran A, Joyner M, Lin LL, Colbert LE, Gillison ML, Klopp AH. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation. Clin Cancer Res None(None):None, 2024. PMID: 39680029.
Lee KL, Sarovar V, Lam JO, Leyden WA, Alexeeff SE, Lea AN, Hechter RC, Hu H, Marcus JL, Yuan Q, Kramer JR, Lin LL, Chiao EY, Towner WJ, Horberg MA, Silverberg MJ. Excess Mortality in Persons with Concurrent HIV and Cancer Diagnoses: A Retrospective Cohort Study. Cancer Epidemiol Biomarkers Prev 33(12):1698-1705, 2024. PMID: 39269284.
Lin LL, Wong F, Lin R, Yap T, Litton JK. Pharmacodynamic Activity of [(18)F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With BRCA1/2-Mutated Breast Cancer Receiving Talazoparib. JCO Precis Oncol 8(None):e2400303, 2024. PMID: 39208372.
DeCesaris C, Wilson T, Kim J, Burt L, Grant J, Harkenrider MM, Huang J, Jhingran A, Kidd E, Konski A, Lin L, MD, Small W, Suneja G, Gaffney D. Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, “SAVE” Trial. Pract Radiat Oncol None(None):None. e-Pub 2024. PMID: None.
Kim M, Maldonado JA, Pandey P, El Alam MB, Kouzy R, Christopherson K, Minsky BD, Nugyen QN, Grosshans D, Lin LL, Mitchell MP, Klopp AH, Lee PP, Bird J, Satcher R, Lewis VO, Lin PP, Tang C, Koong AC, Moon B, Colbert LE. Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic. BMJ Support Palliat Care None(None):None, 2024. e-Pub 2024. PMID: 38843933.
Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, Schmeler KM, Eifel PJ, Jhingran A, Lin LL, Joyner MM, Zhang J, Futreal A, Klopp AH, Colbert LE. Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy. Brachytherapy 23(2):123-135, 2024. e-Pub 2023. PMID: 38129211.
Court LE, Aggarwal A, Jhingran A, Naidoo K, Netherton T, Olanrewaju A, Peterson C, Parkes J, Simonds H, Trauernicht C, Zhang L, Beadle BM, Assistant Consortium RP. Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to Cancer Care. JCO Glob Oncol 10:e2300376, 2024. PMID: 38484191.
Freedman, GM, Li, T, Garver, E, Shillington, K, Shinkle, B, Tchou, J, Fayanju, OM, Lin, LL, Taunk, NK. Five-Year Outcomes of a Phase 1/2 Trial of Accelerated Partial Breast Irradiation Using Proton Therapy for Women With Stage 0-IIA Breast Cancer. Advances in Radiation Oncology 9(2), 2024. PMID: 38405317.
Yoder AK, Lakomy DS, Wu J, Andring LM, Corrigan KL, Fellman B, Jhingran A, Klopp AH, Colbert LE, Soliman PT, Frumovitz MM, Peterson SK, Lin LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. e-Pub 2023. PMID: 37914588.
Sammouri J, Venkatesan AM, Lin LL, Jhingran A, Klopp AH, Joyner MM, Eifel PJ, Colbert LE. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement. Gynecol Oncol 180(None):24-34, 2024. e-Pub 2023. PMID: 38041900.
Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, Bronk JK, Sammouri J, Yanamandra AV, Olvera AV, Carlin LG, Sims T, Delgado Medrano AY, Napravnik TC, O'Hara M, Lin D, Abana CO, Li HX, Eifel PJ, Jhingran A, Joyner M, Lin L, Ramondetta LM, Futreal AM, Schmeler KM, Mathew G, Dorta-Estremera S, Zhang J, Wu X, Ajami NJ, Wong M, Taniguchi C, Petrosino JF, Sastry KJ, Okhuysen PC, Martinez SA, Tan L, Mahmud I, Lorenzi PL, Wargo JA, Klopp AH. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. e-Pub 2023. PMID: 37863066.
Andring LM, Corrigan KL, Rooney M, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Kazantsev T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. Patient Reported Outcomes for Women Undergoing Definitive Chemoradiation for Gynecologic Cancer: A Prospective Clinical Trial. Pract Radiat Oncol 13(6):e538-e546. e-Pub 2023. PMID: 37597615.
Simiele SJ, Charyyev S, Lin L, Kim L, Wang D, Gronberg MP, Subcommittee MC. MPLA case: I didn't realize those were the expectations!. J Appl Clin Med Phys 24(8):e14089, 2023. e-Pub 2023. PMID: 37415409.
Lin LL, Ndlovu N, Lowenstein J, Wirth M, Lee J, Stier EA, Garg M, Kotzen J, Kadzatsa W, Palefsky J, Krown SE, Einstein MH. Quality Assurance in Clinical Trials Requiring Radiotherapy in sub-Saharan Africa. Int J Radiat Oncol Biol Phys 116(2):439-447, 2023. e-Pub 2022. PMID: 36493958.
Lin LL, Msadabwe SC, Chiao E. Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer. Int J Radiat Oncol Biol Phys 116(2):459-462, 2023. PMID: 37179093.
Berlin, E, Yegya-Raman, N, Garver, E, Li, T, Lin, LL, Taunk, NK. Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers. Gynecologic oncology 172:92-97, 2023. PMID: 37003073.
Pantel AR, Gitto SB, Makvandi M, Kim H, Medvedv S, Weeks JK, Torigian DA, Hsieh CJ, Ferman B, Latif NA, Tanyi JL, Martin LP, Lanzo SM, Liu F, Cao Q, Mills GB, Doot RK, Mankoff DA, Mach RH, Lin LL, Simpkins F. [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a pilot study. Clin Cancer Res 29(8):1515-1527, 2023. e-Pub 2022. PMID: 36441795.
Gjyshi O, Grippin A, Andring L, Jhingran A, Lin LL, Bronk J, Eifel PJ, Joyner MM, Sastry JK, Yoshida-Court K, Solley TN, Napravnik TC, O'Hara MP, Hegde VL, Colbert LE, Klopp AH. Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer. Clin Transl Radiat Oncol 39:100578, 2023. e-Pub 2023. PMID: 36935860.
Kamrava M, Leung E, Bachand F, Beriwal S, Chargari C, D'Souza D, Erickson B, Fokdal L, Han K, Harkenrider M, Lin L, Mahantshetty U, Nesvacil N, Ravi A, Schmid M, Vigneault E, Westerveld H, Yashar C, Nout R. GEC-ESTRO (ACROP)-ABS-CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina. Int J Radiat Oncol Biol Phys 115(3):654-663, 2023. e-Pub 2022. PMID: 36191741.
Yoder AK, Lakomy DS, Wu J, Andring LM, Fellman B, Colbert LE, Jhingran A, Klopp AH, Soliman P, Peterson SK, Lin LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol) 35(2):e215-e226, 2023. e-Pub 2022. PMID: 36494250.
Diao K, Kizub DA, Ausat N, Mwaba CK, Anakwenze Akinfenwa CP, Cameron CA, Chiao EY, Lombe DC, Msadabwe SC, Lin LL. Perspectives of Zambian Clinical Oncology Trainees in the MD Anderson and Zambia Virtual Clinical Research Training Program (MOZART). Oncologist 27(10):e804-e810, 2022. e-Pub 2022. PMID: 35689473.
Karpinets TV, Wu X, Solley T, El Alam MB, Sims TT, Yoshida-Court K, Lynn E, Ahmed-Kaddar M, Biegert G, Yue J, Song X, Sun H, Petrosino JF, Mezzari MP, Okhuysen P, Eifel PJ, Jhingran A, Lin LL, Schmeler KM, Ramondetta L, Ajami N, Jenq RR, Futreal A, Zhang J, Klopp AH, Colbert LE. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure. BMC Cancer 22(1):945, 2022. e-Pub 2022. PMID: 36050658.
Lakomy DS, Yoder AK, Wu J, Hernandez M, Ayoola-Adeola M, Jhingran A, Klopp A, Soliman P, Peterson SK, Lin LL. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors. Int J Gynecol Cancer 32(10):1266-1275, 2022. e-Pub 2022. PMID: 35680139.
Woodhouse KD, Devlin PM, Kollmeier M, Lin LL, Orio P, Ouhib Z, Song D, Viswanathan AN, Watanabe Y, Yu Y, Small W, Schechter NR. ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy. Am J Clin Oncol 45(6):243-248, 2022. e-Pub 2022. PMID: 35485607.
Diao K, Lombe DC, Mwaba CK, Wu J, Kizub DA, Cameron CA, Chiao EY, Msadabwe SC, Lin LL. Building Capacity for Cancer Research in the Era of COVID-19: Implementation and Results From an International Virtual Clinical Research Training Program in Zambia. JCO Glob Oncol 8:e2100372, 2022. PMID: 35594499.
Saris DH, Smith AJB, Brensinger C, Kim SH, Haggerty AF, Latif N, Cory L, Giuntoli RL, Morgan MA, Lin LL, Ko EM. Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study. Gynecol Oncol Rep 40:100922, 2022. e-Pub 2022. PMID: 35242979.
Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, Eifel PJ, Colbert LE, Lu KH, Klopp AH. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol 164(3):550-557, 2022. e-Pub 2021. PMID: 34974906.
Surasi, DS, Lin, LL, Ravizzini, G, Wong, FC. Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT. Clinical nuclear medicine 47(2):195-196, 2022. PMID: 34507331.
Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
Cory L, Brensinger C, Burger RA, Giuntoli RL, Morgan MA, Latif N, Lin LL, Ko EM. Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma. Gynecol Oncol Rep 39:100930, 2022. e-Pub 2022. PMID: 35111895.
Surasi, Devaki Shilpa Sudha MD, Lin, Lilie MD, Ravizzini, Gregory MD, Wong, Franklin MD. Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT. Clinical Nuclear Medicine 47(2):195-196, 2022. PMID: None.
Young AJ, Pantel AR, Viswanath V, Dominguez TL, Makvandi M, Lee H, Li S, Schubert EK, Pryma DA, Farwell MD, Mach RH, Simpkins F, Lin LL, Mankoff DA, Doot RK. Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted 18F-FluorThanatrace (18F-FTT) PET images of ovarian cancer. J Nucl Med 63(1):44-50, 2022. e-Pub 2021. PMID: 33863820.
Lakomy DS, Wu J, Chapman BV, Yu ZH, Lee B, Klopp AH, Jhingran A, Eifel PJ, Lin LL. Use of specific duodenal dose constraints during treatment planning reduces toxicity after definitive para-aortic radiotherapy for cervical cancer. Pract Radiat Oncol 12(3):e207-e215, 2022. e-Pub 2021. PMID: 34958984.
Huang A, Gunther JR, Lin LL. In Reply to Sindhu et al. Adv Radiat Oncol 7(6):101067, 2022. e-Pub 2022. PMID: 36420206.
Huang A, Gunther JR, Lin LL. Analyzing the Role of Research in the Radiation Oncology Match. Adv Radiat Oncol 7(3):100891, 2022. e-Pub 2022. PMID: 35243182.
Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, Castillo P, Hughes N, Mohammedsaid M, Jhingran A, Klopp AH, Choi S, Fuller CD, Lin LL. Clinical implementation and initial experience with a 1.5 Tesla MR-linac for MR-guided radiotherapy for gynecologic cancer: An R-IDEAL stage 1/2a first in humans/feasibility study of new technology implementation. Pract Radiat Oncol 12(4):e296-e305, 2022. e-Pub 2022. PMID: 35278717.
Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol 12(5):e423-e433, 2022. e-Pub 2022. PMID: 35390531.
MacDuffie E, Bvochora-Nsingo M, Chiyapo S, Balang D, Chambers A, George JM, Tuli S, Lin LL, Zetola NM, Ramogola-Masire D, Grover S. Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana. Infect Agent Cancer 16(1):55, 2021. e-Pub 2021. PMID: 34344430.
Anakwenze Akinfenwa CP, Ibraheem A, Nwankwo K, Lasebikan N, Ali-Gombe M, Aliyu UM, Ikhile E, Adegboyega O, Abdullahi A, Klopp AH, Schmeler K, Lin LL, Jhingran A, Page BR, Leng J, Grover S, Ntekim A. Emerging Use of Public-Private Partnerships in Public Radiotherapy Facilities in Nigeria. JCO Glob Oncol 7:1260-1269, 2021. PMID: 34351813.
Yoder AK, Lakomy DS, Dong Y, Raychaudhury S, Royse K, Hartman C, Richardson P, White DL, Kramer JR, Lin LL, Chiao E. The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study. BMC Cancer 21(1):776, 2021. e-Pub 2021. PMID: 34225709.
Garcia-Soto AE, McKenzie ND, Whicker ME, Pearson JM, Jimenez EA, Portelance L, Hu JJ, Lucci JA, Qureshi R, Kossenkov A, Schwartz L, Mills GB, Maity A, Lin LL, Simpkins F. Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer. Cancer 127(13):2279-2293, 2021. e-Pub 2021. PMID: 33932031.
Sezen D, Patel RR, Tang C, Onstad M, Nagarajan P, Patel SP, Welsh JW, Lin LL. Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma. Gynecol Oncol 161(3):645-652, 2021. e-Pub 2021. PMID: 33795130.
Yeboa, DN, Anakwenze, C, Nguyen, J, Amaya, D, De Gracia, B, Ning, M, Cox, V, De, BS, Smith, B, Lin, LL, Beddar, S, Hoang, H, Koong, A, Liao, Z. Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic. Advances in Radiation Oncology 6(3), 2021. PMID: 33686374.
Latif N, Oh J, Brensinger C, Morgan M, Lin LL, Cory L, Ko EM. Lymphadenectomy is associated with an increased risk of postoperative venous thromboembolism in early stage endometrial cancer. Gynecol Oncol 161(1):130-134, 2021. e-Pub 2021. PMID: 33551203.
Sims TT, El Alam MB, Karpinets TV, Dorta-Estremera S, Hegde VL, Nookala S, Yoshida-Court K, Wu X, Biegert GWG, Delgado Medrano AY, Solley T, Ahmed-Kaddar M, Chapman BV, Sastry KJ, Mezzari MP, Petrosino JF, Lin LL, Ramondetta L, Jhingran A, Schmeler KM, Ajami NJ, Wargo J, Colbert LE, Klopp AH. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation. Commun Biol 4(1):237, 2021. e-Pub 2021. PMID: 33619320.
El Alam MB, Sims TT, Kouzy R, Biegert GWG, JABI J, Karpinets TV, Yoshida-Court K, Wu X, Delgado-Medrano AY, Mezzari MP, Ajami NJ, Solley T, Ahmed-Kaddar M, Lin LL, Ramondetta L, Jazaeri A, Jhingran A, Eifel PJ, Schmeler KM, Wargo J, Klopp AH, Colbert LE. A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers. PLoS One 16(3):e0247905, 2021. e-Pub 2021. PMID: 33662003.
Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch J, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN. The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes. Gynecol Oncol 159(3):607-610, 2020. e-Pub 2020. PMID: 32972783.
Ko EM, Brensinger CM, Cory L, Giuntoli RL, Haggerty AF, Latif NA, Aviles D, Martin L, Morgan MA, Lin LL. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology. Gynecol Oncol 159(2):394-401, 2020. e-Pub 2020. PMID: 32800655.
Lin LL, Lakomy DS, Chiao EY, Strother RM, Wirth M, Cesarman E, Borok M, Busakhala N, Chibwesha CJ, Chinula L, Ndlovu N, Orem J, Phipps W, Sewram V, Vogt SL, Sparano JA, Mitsuyasu RT, Krown SE, Gopal S. Clinical Trials for Treatment and Prevention of HIV-associated Malignancies in sub-Saharan Africa: Building Capacity and Overcoming Barriers. JCO Glob Oncol 6:1134-1146, 2020. PMID: 32697667.
Lombe DC, Mwab CK, Msadabwe SC, Banda L, Mwale M, Pupwe G, Kamfwa P, Kanduza M, Harry M, Maliti B, Simbeye K, Hachizo P, Lilie LL, Chiao E, Lishimpi K. Zambia’s National Cancer Centre response to the COVID-19 pandemic—an opportunity for improved care. eCancer, 2020. e-Pub 2020. PMID: None.
Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, Yoshida-Court K, Petrosino JF, Mikkelson MD, Lin LL, Eifel P, Zhang J, Ramondetta LM, Jhingran A, Sims TT, Schmeler K, Okhuysen P, Colbert LE, Klopp AH. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys 107(1):163-171, 2020. e-Pub 2020. PMID: 31987960.
Lakomy DS, Urbauer DL, Westin SN, Lin LL. Phase I study of the PARP inhibitor talazoparib with radiation therapy for locally recurrent gynecologic cancers. Clin Transl Radiat Oncol 21:56-61, 2020. e-Pub 2019. PMID: 31993510.
Vogel J, Lin L, Rengan R. Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer. Transl Lung Cancer Res 9(1):154-155, 2020. PMID: 32207751.
Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy 19(4):427-437, 2020. e-Pub 2019. PMID: 31786169.
Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, Fitch K, Harkenrider MM, Holschneider CH, Kamrava M, Leung E, Lin LL, Mayadev JS, Morcos M, Nwachukwu C, Petereit D, Viswanathan AN. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 10(4):220-234, 2020. e-Pub 2020. PMID: 32473857.
Rengan R, Mick R, Pryma DA, Lin LL, Christodouleas J, Plastaras JP, Simone CB, Gupta AK, Evans TL, Stevenson JP, Langer CJ, Kucharczuk J, Friedberg J, Lam S, Patsch D, Hahn SM, Maity A. Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial. JAMA Oncol 5(10):1464-1472, 2019. e-Pub 2019. PMID: 31436839.
Vogel J, Wang X, Troxel AB, Simone CB, Rengan R, Lin LL. Prospective assessment of demographic characteristics associated with worse health related quality of life measures following definitive chemoradiation in patients with locally advanced non-small cell lung cancer. Transl Lung Cancer Res 8(4):332-339, 2019. PMID: 31555509.
Singer L, Damast S, Lin L, Taunk N, Lee LJ, Albuquerque K, Chino J, Petereit D, Joyner M, Fields E. Development of a Multi-Institutional Simulation-Based Gynecologic Brachytherapy Curriculum. Int J Radiat Oncol Biol Phys 104(5):1175-1176, 2019. PMID: 31327414.
Grover S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, Bhatia RK, Balang D, Chiyapo SP, Luckett R, Ramogola-Masire D, Dryden-Peterson SL, Lin LL, Shin SS, Zetola NM. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana. Cancer 125(10):1645-1653, 2019. e-Pub 2019. PMID: 30801696.
Demissei BG, Freedman G, Feigenberg SJ, Plastaras JP, Maity A, Smith AM, McDonald C, Sheline K, Simone CB, Lin LL, Carver JR, Liu P, Zhang L, Bekelman JE, Ky B. Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma. Int J Radiat Oncol Biol Phys 103(4):851-860, 2019. e-Pub 2018. PMID: 30445173.
Sapienza LG, Ning MS, Jhingran A, Lin LL, Leão CR, da Silva BB, Pellizzon ACA, Gomes MJL, Baiocchi G. Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study. Clin Transl Radiat Oncol 14:40-46, 2019. e-Pub 2018. PMID: 30555940.
Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis. Brachytherapy 18(5):620-626, 2019. e-Pub 2019. PMID: 31160198.
Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy 18(4):445-452, 2019. e-Pub 2019. PMID: 30992185.
Sapienza LG, Jhingran A, Kollmeier MA, Lin LL, Calsavara VF, Gomes MJL, Baiocchi G. Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis. Gynecol Oncol 151(3):573-578, 2018. e-Pub 2018. PMID: 30333082.
Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys 102(3):593-600, 2018. e-Pub 2018. PMID: 30017792.
Maity A, Mick R, Huang AC, George SM, Farwell MD, Lukens JN, Berman AT, Mitchell TC, Bauml J, Schuchter LM, O'Hara M, Lin LL, Demichele A, Christodouleas JP, Haas NB, Patsch DM, Hahn SM, Minn AJ, Wherry EJ, Vonderheide RH. A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Br J Cancer 119(10):1200-1207, 2018. e-Pub 2018. PMID: 30318516.
Yalamanchi P, Shabason JE, Zhang X, Ko EM, Lin LL. Use of Aggressive Surveillance for Locoregional Edometrial Cancer After Local Therapy. Int J Gynecol Cancer 28(7):1264-1270, 2018. PMID: 30036223.
Xanthopoulos EP, Grover S, Puri PM, Corradetti MN, Heilbroner SP, Mitra N, Simone CB, Lin LL. Survival benefit of Adjuvant radiation therapy in node-positive vulvar cancer. Am J Clin Oncol 41(9):845-850, 2018. PMID: 30134287.
Bi Y, Verginadis II, Dey S, Lin L, Guo L, Zheng Y, Koumenis C. Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas. Gynecol Oncol 150(3):534-544, 2018. e-Pub 2018. PMID: 30025822.
Grover S, Bvochora-Nsingo M, Yeager A, Chiyapo S, Bhatia R, MacDuffie E, Puri P, Balang D, Ratcliffe S, Narasimhamurthy M, Gwangwava E, Tsietso S, Kayembe MKA, Ramogola-Masire D, Dryden-Peterson S, Mahantshetty U, Viswanathan AN, Zetola NM, Lin LL. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. Int J Radiat Oncol Biol Phys 101(1):201-210, 2018. e-Pub 2018. PMID: 29619965.
Makvandi M, Pantel A, Schwartz L, Schubert E, Xu K, Hsieh CJ, Hou C, Kim H, Weng CC, Winters H, Doot R, Farwell MD, Pryma DA, Greenberg RA, Mankoff DA, Simpkins F, Mach RH, Lin LL. Evaluating PARP-1 with PET imaging in ovarian cancer. J Clin Invest 128(97992):2116-2126, 2018. e-Pub 2018. PMID: 29509546.
Hanlon A, Small W, Strauss J, Lin LL, Hanisch L, Huang L, Bai J, Wells J, Bruner DW. Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study. Cancer Nurs 41(3):200-209, 2018. e-Pub 2017. PMID: 28437283.
Guttmann DM, Gabriel P, Kennedy C, Rate W, Grizos W, Nagda S, Wojtowicz L, Lin, Freedman GM. Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whold breast. Breast J 24(2):128-132, 2018. e-Pub 2017. PMID: 28703444.
Garcia RM, Hanlon A, Small W, Strauss JB, Lin L, Wells J, Bruner DW. The relationship between Body Mass Index and Sexual Function in Endometrial Cancer. Oncol Nurs Forum 45(1):25-32, 2018. PMID: 29251291.
Xu MJ, Maity A, Vogel J, Kirk M, Zhai H, Both S, Lin LL. Proton Therapy Reduces Normal Tissue Dose in Extended Field Pelvic Radiation for Endometrial Cancer. Int J Part Ther 4(3):1-11, 2018. e-Pub 2018. PMID: 31773009.
Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. Am J Clin Oncol 40(6):598-604, 2017. PMID: 26237194.
Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature. Brachytherapy. e-Pub 2017. PMID: 28888417.
Baumann BC, Zeng C, Freedman GM, Verginadis II, MacArthur KM, Lin LL, Vachani C, Koumenis C, Solberg TD, Metz JM. Avoiding antiperspirants during breast radiation therapy: Myth or sound advice?. Radiother Oncol 124(2):204-207, 2017. e-Pub 2017. PMID: 28733055.
Sander Effron S, Makvandi M, Lin LL, Xu K, Li S, Lee H, Hou C, Pryma DA, Koch C, Mach RH. PARP-1 Expression Quantified by [18F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy. Cancer Biother Radiopharm 32(1):9-15, 2017. e-Pub 2017. PMID: 28118040.
Taku N, Dise J, Kenton O, Yin L, Teo BK, Lin LL. Quantification of vaginal motion associated with daily endorectal balloon placement during whole pelvis radiotherapy for gynecologic cancers. Radiother Oncol 120(3):532-536, 2016. e-Pub 2016. PMID: 27247058.
Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, Ramogola-Masire D, Kebabonye-Pusoentsi M, Clayman R, Mapes AC, Tapela N, Asmelash A, Medhin H, Viswanathan AN, Russell AH, Lin LL, Kayembe MK, Mmalane M, Randall TC, Chabner B, Lockman S. HIV Infection and Survival Among Women With Cervical Cancer. J Clin Oncol 34(31):None. e-Pub 2016. PMID: 27573661.
Dean LT, Zhang X, Latif N, Giuntoli R, Lin LL, Haggerty A, Kim S, Shalowitz D, Stashwick C, Simpkins F, Burger R, Morgan M, Ko E, Schmitz K. Race-based disparities in loss of functional independence after hysterectomy for uterine cancer. Support Care Cancer 24(8):3573-80, 2016. e-Pub 2016. PMID: 27025595.
Xu MJ, Kirk M, Zhai H, Lin LL. Bag and loop small bowel contouring strategies differentially estimate small bowel dose for post-hysterectomy women receiving pencil beam scanning proton therapy. Acta Oncol 55(7):900-8, 2016. e-Pub 2016. PMID: 26927612.
Yan C, Fischer JP, Freedman GM, Basta MN, Kovach SJ, Serletti JM, Lin LL, Wu LC. The Timing of Breast Irradiation in Two-Stage Expander/Implant Breast Reconstruction. Breast J 22(3):322-9, 2016. e-Pub 2016. PMID: 26864463.
Lin LL, Kirk M, Scholey J, Taku N, Kiely JB, White B, Both S. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer. Int J Radiat Oncol Biol Phys 95(1):181-9, 2016. e-Pub 2015. PMID: 26372435.
Zetola N, Grover S, Modongo C, Chiyapo S, Nsingo-Bvochara M, Narasimhamurthy M, Lin LL, Jarvis J, Shin S, Robertson E. Collision of Three Pandemics: The Coexistence of Cervical Cancer, HIV Infection, and Prior Tuberculosis in the Sub-Saharan Country of Botswana. J Glob Oncol 2(1):47-50, 2016. PMID: 28717682.
Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women with Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Int J Gynecol Cancer 26(1):141-8, 2016. PMID: 26509850.
Li YR, Kirk M, Lin LL. Proton Therapy for Vaginal Reirradiation. Int J Part Ther 3(2):320-326, 2016. e-Pub 2016. PMID: 28989947.
Zhang X, Haggerty AF, Brown JC, Giuntoli R, Lin LL, Simpkins F, Dean LT, Ko E, Morgan MA, Schmitz KH. The prescription or proscription of exercise in endometrial cancer care. Gynecol Oncol 139(1):155-9, 2015. e-Pub 2015. PMID: 26307400.
Dise J, Liang X, Scheuermann J, Anamalayil S, Mesina C, Lin LL, Teo BK. Development and evaluation of an automatic interstitial catheter digitization tool for adaptive high-dose-rate brachytherapy. Brachytherapy 14(5):619-25, 2015. e-Pub 2015. PMID: 26073225.
Lin LL, Vennarini S, Dimofte A, Ravanelli D, Shillington K, Batra S, Tochner Z, Both S, Freedman G. Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer. Acta Oncol 54(7):1032-9, 2015. e-Pub 2015. PMID: 25789715.
Xanthopoulos EP, Handorf E, Simone CB, Grover S, Fernandes AT, Sharma S, Corradetti MN, Evans TL, Langer CJ, Mitra N, Shah A, Apisarnthanarax S, Lin LL, Rengan R. Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. Pract Radiat Oncol 5(4):e355-63, 2015. e-Pub 2015. PMID: 25649540.
Teo BK, Bonner Millar LP, Ding X, Lin LL. Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation. Radiother Oncol 115(2):195-202, 2015. e-Pub 2015. PMID: 26002306.
White BM, Vennarini S, Lin LL, Freedman G, Santhanam A, Low DA, Both S. Accuracy of routine treatment planning 4-dimensional and deep-inspiration breath-hold computed tomography delineation of the left anterior descending artery in radiation therapy. Int J Radiat Oncol Biol Phys 91(4):825-31, 2015. PMID: 25752397.
Fang P, Tan KS, Grover S, McFadien MK, Troxel AB, Lin LL. Psychosocial encounters correlates with higher patient-reported functional quality of life in gynecological cancer patients receiving radiotherapy. Radiat Oncol 10:34, 2015. e-Pub 2015. PMID: 25657054.
Brown JC, Lin LL, Segal S, Chu CS, Haggerty AE, Ko EM, Schmitz KH. Physical activity, daily walking, and lower limb lymphedema associate with physical function among uterine cancer survivors. Support Care Cancer 22(11):3017-25, 2014. e-Pub 2014. PMID: 24906839.
Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 90(2):320-8, 2014. PMID: 25304792.
Lin LL, Brown JC, Segal S, Schmitz KH. Quality of life, body mass index, and physical activity among uterine cancer patients. Int J Gynecol Cancer 24(6):1027-32, 2014. PMID: 24927246.
Latif NA, Haggerty A, Jean S, Lin LL, Ko E. Adjuvant therapy in early-stage endometrial cancer: a systematic review of the evidence, guidelines, and clinical practice in the U.S. Oncologist 19(6):645-53, 2014. e-Pub 2014. PMID: 24821823.
Lin LL, Mick R, Ware J, Metz J, Lustig R, Vapiwala N, Rengan R, Kennedy AR. Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncol Lett 7(4):1151-1158, 2014. e-Pub 2014. PMID: 24944684.
Li H, Tennapel MJ, Ahmed A, Lin LL, Bhatia S, Jacobson G. Uterine carcinosarcoma confined to the pelvis:A retrospective review and outcome analysis. Journal of Radiotherapy, 2014. PMID: None.
Grover S, Xu MJ, Yeager A, Rosman L, Groen RS, Chackungal S, Rodin D, Mangaali M, Nurkic S, Fernandes A, Lin LL, Thomas G, Tergas AI. A systematic review of radiotherapy capacity in low- and middle-income countries. Front Oncol 4:380, 2014. e-Pub 2015. PMID: 25657930.
Welliver MX, Lin LL. Evaluation of a balloon-based vaginal packing system and patient controlled analgesia for patients with cervical cancer undergoing high dose rate intracavitary brachytherapy. Practical Radiation Oncology 3(4):263-268, 2013. PMID: None.
Fang P, Tan KS, Troxel AB, Rengan R, Freedman G, Lin LL. High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy. Breast Cancer Res Treat 141(1):125-33, 2013. e-Pub 2013. PMID: 23942874.
Xanthopoulos EP, Corradetti MN, Mitra N, Fernandes AT, Kim M, Grover S, Christodouleas JP, Evans TL, Stevenson JP, Langer CJ, Lee TT, Pryma DA, Lin LL, Simone CB, Apisarnthanarax S, Rengan R. Impact of PET staging in limited-stage small-cell lung cancer. J Thorac Oncol 8(7):899-905, 2013. PMID: 23608814.
Rey F, Chang C, Mesina C, Dixit N, Kevin Teo BK, Lin LL. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer. Radiother Oncol 107(1):112-6, 2013. e-Pub 2013. PMID: 23333023.
Showalter SL, Grover S, Sharma S, Lin LL, Czerniecki BJ. Factors influencing surgical and adjuvant therapy in stage I breast cancer: a SEER 18 database analysis. Ann Surg Oncol 20(4):1287-94, 2013. e-Pub 2012. PMID: 23135311.
Grover S, Showalter S, Kraft KH, Suneja G, Lin LL. The impact of race and partner status on patterns of care and survival in young women with early-stage cervical cancer. International Journal of Gynecological Cancer: official journal of the International Gynecological Cancer Society 23(3):494-9, 2013. PMID: None.
Bahng AY, Chu C, Wileyto P, Rubin S, Lin LL. Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma. J Gynecol Oncol 23(4):257-64, 2012. e-Pub 2012. PMID: 23094129.
Lin LL, Silvoniemi A, Stubbs JB, Rengan R, Suilamo S, Solin O, Divgi C, Eskola O, Sorger JM, Stabin MG, Kachur A, Hahn SM, Grönroos TJ, Forsback S, Evans SM, Koch CJ, Minn H. Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. Cancer Biother Radiopharm 27(7):412-9, 2012. e-Pub 2012. PMID: 22897720.
Lin LL, Hertan L, Rengan R, Teo BK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys 83(2):670-5, 2012. e-Pub 2011. PMID: 22208974.
Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin LL, Rengan R. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 83(1):340-7, 2012. e-Pub 2011. PMID: 22104359.
Rengan R, Mick R, Pryma D, Rosen MA, Lin LL, Maity AM, Evans TL, Stevenson JP, Langer CJ, Kucharczuk J, Friedberg J, Prendergast S, Sharkoski T, Hahn SM. A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response. J Thorac Oncol 7(4):709-15, 2012. PMID: 22425919.
Milby Berman A, Both S, Ingram M, Lin LL. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies. Int J Radiat Oncol Biol Phys 82(3):e477-84, 2012. PMID: None.
Bahng AY, Dagan A, Bruner DW, Lin LL. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 82(2):667-73, 2012. e-Pub 2011. PMID: 21300451.
Liao JB, Jean S, Wilkinson-Ryan I, Ford AE, Tanyi JL, Hagemann AR, Lin LL, McGrath CM, Rubin SC. Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity. Gynecol Oncol 120(1):108-12, 2011. PMID: 20937524.
Fernandes AT, Shen J, Finlay J, Mitra N, Evans T, Stevenson J, Langer C, Lin LL, Hahn S, Glatstein E, Rengan R. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. Radiother Oncol 95(2):178-84, 2010. e-Pub 2010. PMID: 20356642.
Hill-Kayser CE, Avery S, Mesina CF, James P, Friedberg JS, Cengel K, Lin LL, Hahn SM, Rengan R. Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques. J Thorac Oncol 4(11):1431-7, 2009. PMID: 19745767.
Schwarz JK, Lin LL, Siegel BA, Miller TR, Grigsby PW. .: (18)-F-Fluorodeoxyglucose positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 72(5):1502-7, 2008. PMID: None.
Nemani D, Mitra N, Guo M, Lin LL. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol 111(1):82-8, 2008. PMID: 18674808.
Macdonald DM, Lin LL, Biehl K, Mutic S, Nantz R, Grigsby PW. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer. Int J Radiat Oncol Biol Phys 71(2):618-24, 2008. e-Pub 2008. PMID: 18407429.
Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr 1(2):126-30, 2008. PMID: 18352781.
Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 106(1):215-20, 2007. e-Pub 2007. PMID: 17482665.
Lin LL, Mutic S, Low DA, LaForest R, Vicic M, Zoberi I, Miller TR, Grigsby PW. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys 67(1):91-6, 2007. PMID: 17189066.
Lin LL, Yang Z, Mutic S, Miller TR, Grigsby PW. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys 65(1):177-81, 2006. e-Pub 2006. PMID: 16545921.
Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 101(1):147-51, 2006. e-Pub 2005. PMID: 16263155.
Lin LL, Mutic S, Malyapa RS, Low DA, Miller TR, Vicic M, Laforest R, Zoberi I, Grigsby PW. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 63(5):1494-501, 2005. e-Pub 2005. PMID: 16154713.
Lin LL, Grigsby PW, Powell MA, Mutch DG. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys 63(2):500-4, 2005. PMID: 16168841.
Lin LL, Myerson RJ, Drebin JA, Linehan DC, Solis J, Strasberg SM, Tan B, Thorstad WL, Picus J. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. American Journal of Clinical Oncology 23(3):234-41, 2005. PMID: None.
Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, Gius D. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 21(41):6317-27, 2002. PMID: 12214272.
Beckman DL, Lin LL, Quinones ME, Longmore GD. Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin. Blood 94(8):2667-75, 1999. PMID: 10515870.

Abstracts

Guttmann DM, Gabriel P, Lin LL, Kennedy C, Rate WR, Grizos WT, Nagda S, Wojtowicz L, Freedman GM. Contemporary Forward Planned 3-D Conformal Radiotherapy: A Wise Choice for Whole-Breast Radiation. Int J Radiat Oncol Biol Phys. Elsevier 93(3):E22, 2015. PMID: None.
White B, Blanco KJ, Vennarini S, Lin LL, Freedman G, Santhanam A, Low D, Both S. TU-EF-304-04: A Heart Motion Model for Proton Scanned Beam Chest Radiotherapy. Medical Physics 42(6):3615, 2015. PMID: None.
E Xanthopoulos E, Corradetti M, Grover S, Fernandes A, Kim M, Simone C, Apisarnthanarax S, Lin LL, Rengan R. A strategy to reduce acute toxicity from chemoradiation therapy for limited-stage small cell lung cancer. Journal of Thoracic Oncology, 2012. PMID: None.
Grigsby PW, Lin LL, Yang J, Zoberi I, Miller TR. Physiologic volume reduction of primary cervical carcinoma. , May 2005 Notes: Oral presentation, American Brachytherapy Society, San Francisco. Brachytherapy 4(2):79, 2005. PMID: None.
Lin LL, Zoberi I, Mutch D, Grigsby PW. Brachytherapy alone for intermediate risk endometrial cancer. May 2005 Notes: Poster Presentation, American Brachytherapy Society, San Francisco. Brachytherapy 4(2), 2005. PMID: None.
Lin LL, Mansur DB, Leonard J, Lockett MA, Michalski JM. Failure patterns and long-term outcome in pediatric patients treated for craniopharyngioma. 2004 International Society of Pediatric Neuro-Oncology, Boston, 2004. PMID: None.
Lin LL, Grigsby PW, Siegel BA, Dehdashti F. Comparison of FDG-PET and CT evaluation of recurrent endometrial cancer at the vaginal apex. Nuklearmedizin, January 2004 Notes: Oral Presentation, 26th International Symposium on Radioactive Isotopes in clinical Medicine and Research, Bad Gastein, Austria 42(A169), 2003. PMID: None.

Book Chapters

Feddock, J, Kunos, C, Pompos, A, Albuquerque, K, Lin, LL. Chapter 8: Stereotactic ablative radiotherapy and other newer treatment delivery techniques for gynecologic cancers. In: Radiation Therapy Techniques for Gynecological Cancers. None. None, 2018.
Lin LL. Commentary: Long-term survival outcomes following internal mammary node irradiation in Stage II-III breast cancer: results of a large retrospective study with 12 year follow-up. In: Breast Diseases: A Yearbook Quarterly. None. None, 76-77, 2014.
Bvochara M, Grover S, Gierga DP, Makufa R, Efstathiou JA, Dixit N, Clayman RH, Russell AH, Lin LL, Kasese J. Cervical brachytherapy exchange: steps towards oncology capacity building in Botswana. In: The Oncologist. None. None, e1-2, 2014.
Lin LL. IMRT for gynecologic cancers. In: Practical Essentials of Intensity Modulated Radiation Therapy. None. Lippincott Williams & Wilkins, 2013.
Lin LL, Freedman G. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-up. In: series with long-term follow-up. None. None, 97-98, 2013.
Hristov B, Lin LL. Vaginal Cancer. In: Radiation oncology: A question based review. None. None, 2011.
Zeng J, Lin LL. Cervical Cancer. In: Radiation Oncology: A Question Based Review. None. None, 2011.
Tuli R, Lin LL. Ovarian Cancer. In: Radiation oncology: A question based review. None. None, 2011.
Bonner Millar L, Lin LL. Radiation therapy for gynecologic malignancies. In: Manual of Gynecologic Oncology. None. World Scientifi, 2011.
Lin LL, Grigsby PW. Cervical cancer: Positron emission tomography and positron emission tomography/computed tomography. In: Methods of Cancer Diagnosis, Therapy and Prognosis. None. Springer, 2010.
Chu C, Lin LL, Rubin S. Cancer of the uterine body. In: Cancer: Principles and Practice of Oncology. 8th. Raven, 2008.
Lin LL, Dehdashti F, Siegel B, Grigsby PW. PET and PET/CT of tumors of the female genital tract. In: Clinical Molecular Anatomic Imaging: PET, PET/CT, and SPECT/CT Integrated Modality Imaging. 2nd. Lippincott Williams and Wilkins, 427-442, 2007.

Books (edited and written)

Levine DA, Gaillard S, Lin LL, Chi DS, Berchuck A, Dizon DS, Yashar CM. Handbook for Principals and Practice of Gynecologic Oncology. Ed(s) 3rd Edition. Wolters Kluwer, 2020.

Less

Selected Presentations & Talks

National Presentations

2024. Gynecologic MDC Review | R6-CRO07C. Invited. RSNA. Chicago, Illinois, US.
2023. Moderator, GYN Case Based Multidisciplinary Review: Magnetic Resonance Imaging, OB/Gynecology, Oncologic Imaging, Radiation Oncology. Conference. RSNA. Chicago, IL, US.
2023. Multidisciplinary Patient-Based Approach to Challenging Situations with Cervix Cancer. Conference. ASTRO. San Diego, CA, US.
2023. Brachytherapy in low- and middle-income countries. Invited. Asian Society of Gynecologic Oncology (ASGO), US.
2023. Management of node positive vulvar cancer. Invited. ACRO. Orlando, FL, US.
2022. Moderator, Case-based discussion of challenging patients with uterine cancer. Conference. ASTRO. San Antonio, TX, US.
2022. GYN Session III: Which Imaging is Best for Image-Guided Brachytherapy? Pros and Cons of CT, MRI and TRUS. Invited. American Brachytheraphy Society. Denver, CO, US.
2022. Moderator, Scientific Session: GYN Proffered Papers II. Invited. American Brachytherapy Society. Denver, CO, US.
2022. Practical Strategies for Performing Hybrid Interstitial Applicators for Cervical Cancer Brachytherapy. Invited. American Brachytherapy Society, US.
2022. ABS & ROVER presents a Brachytherapy Panel: Case-Based Teaching Sessions. Invited. American Brachytherapy Society, US.
2021. Gynecologic - Case-based Multidisciplinary Review. Invited. Radiological Society of North America. Chicago, IL, US.
2021. Invited Speaker, Practical Management of Vulvar and Vaginal Cancers: Standard and Challenging Scenarios. Invited. American Society of Radiation Oncology (ASTRO) Annual Meeting Educational Session. Chicago, IL, US.
2021. Moderator, Bridging the Gap: Highlighting Efforts to Build Radiation Oncology Capacity Globally. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting Educational Session. Chicago, IL, US.
2020. Gynecologic-Case-based Multidisciplinary Review (An Interactive Session). Invited. RSNA Annual Meeting, US.
2020. Abstract Reviewer, Gynecologic section. Conference. American Society of Radiation Oncology (ASTRO). Miami, FL, US.
2019. Gynecologic-Case-based Multidisciplinary Review. Invited. RSNA Annual Meeting. Chicago, IL, US.
2019. Abstract Reviewer, Gynecologic section. Conference. American Society of Radiation Oncology (ASTRO). Chicago, IL, US.
2019. Controversial Cases in Locally Advanced Endometrial Cancer. Invited. ASTRO Annual Meeting. Chicago, IL, US.
2019. E-contouring Session for GYN Cancers. Invited. ABS Annual Meeting. Miami, FL, US.
2019. Recent Advances in GYN Cancers. Invited. ASTRO Refresher Course. New Orleans, LA, US.
2018. BOOST: Gynecologic-Case-based Multidisciplinary Review (An Interactive Session). Invited. RSNA Annual Meeting. Chicago, IL, US.
2018. Invited Speaker, ASTRO spring refresher, Updates in the management of gynecologic cancers. Invited. ASTRO spring refresher. Fort Lauderdale, FL, US.
2017. Invited speaker, Use of Image Guidance with IMRT. Invited. ASTRO 59th Annual Conference. San Diego, CA, US.
2017. Moderator, Breast Cancer Clinical Controversies: Throw caution to the wind. Invited. ASTRO Webinar, US.
2016. Moderator, Oral Session. Invited. ASTRO Annual Meeting. Boston, MA, US.
2015. Invited Speaker, Image guided brachytherapy for cervical cancer. Invited. Association of Latin American Therapeutic Radiation Oncology Biennial Meeting. Rosario, US.
2015. Invited Speaker, Brachytherapy in the 21st Century. Invited. Association of Latin American Therapeutic Radiation Oncology Biennial Meeting. Rosario, US.
2015. Invited Speaker, Impact of HIV Status on Cervical Cancer Outcomes in Botswana. Invited. Center for AIDS Research Annual Meeting. Seattle, WA, US.
2015. Abstract Reviewer, Gynecologic section. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting. San Antonio, TX, US.
2015. Invited Speaker, Practice Changing Innovations in Gyn Cancers in the last 2 years. Invited. Apollo Cancer Conclave and Cancer CI. Hyderabad, US.
2015. Invited Speaker, Difficult cases in gynecologic cancers. Invited. Apollo Cancer Conclave and Cancer CI. Hyderabad, US.
2015. Invited Speaker, Adjuvant radiotherapy in early cancer endometrium. Can we avoid?. Invited. Apollo Cancer Conclave and Caner CI. Hyderabad, US.
2014. Abstract Reviewer, Gynecologic section. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting. San Francisco, CA, US.
2014. Poster discussion moderator and discussant. Conference. ASTRO Annual Meeting. San Francisco, CA, US.
2014. Invited Speaker, Difficult Cases in Gynecologic Cancers. Invited. American Radium Society Annual Meeting. St. Thomas, US.
2014. Abstract Reviewer, Gynecologic section. Conference. American Radium Society. St. Thomas, US.
2014. Invited Speaker, Difficult Cases in Gynecologic Cancers. Invited. American Brachytherapy Society Annual Meeting. San Diego, CA, US.
2013. Abstract Reviewer, Gynecologic section. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting. Atlanta, GA, US.
2013. Moderator, Gynecologic Cancers Oral Presentations. Conference. American Brachytherapy Society Annual Meeting. New Orleans, LA, US.
2013. Invited Speaker, Radiotherapy management of cervical cancer. Invited. American Society of Radiation Oncology (ASTRO) Spring Refresher. Chicago, IL, US.
2012. Moderator, GYN I-Endometrial, Vulvar, Vaginal, Ovarian Cancer Oral Presentations. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting. Boston, MA, US.
2012. Invited Speaker, Difficult cases in cervical and vulvar cancer. Invited. American Society of Radiation Oncology (ASTRO) Annual Meeting Educational Session. Boston, MA, US.
2012. Invited Speaker, Complications of gynecologic radiation therapy and their management. Invited. American Brachytherapy Society Gynecologic School. Chicago, IL, US.
2010. Invited Speaker, Controversies in the management of endometrial cancer. Invited. Sino-American Network of Therapeutic Radiation Oncology Bi-ennial Meeting. Hangzhou, US.
2009. Moderator, Molecular Imaging Oral Presentations. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting. Chicago, IL, US.
2009. Abstract Reviewer, Lung section. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting. Chicago, IL, US.
2008. Abstract Reviewer, Lung section. Conference. American Society of Radiation Oncology (ASTRO). Boston, MA, US.
2008. Moderator, Small Cell Lung Cancer Oral Presentations. Conference. The First Symposium of the Sino-American Network for Therapeutic Radiology and Oncology (SANTRO). Beijing, US.
2007. Abstract Reviewer, Lung Section. Conference. American Society of Radiation Oncology (ASTRO) Annual Meeting. Los Angeles, CA, US.
2007. Moderator, Lung Oral Presentations. Conference. American Society of Therapeutic Radiation Oncology (ASTRO) Annual Meeting. Los Angeles, CA, US.

International Presentations

2024. Moving Beyond Platinum Chemotherapy: Novel Agents for Gynecological Malignancies. Invited. TROD-GFS, TR.
2023. Please mind the gap! Improving equity and access to quality gynaecologic radiation therapy globally. Invited. Accademia Nazionale de Medicina, IT.
2023. Impact of social determinants of health on stage at presentation for women with invasive carcinoma of the cervix in Zambia. Conference. AORTIC. Dakar, SN.
2022. Quantifying Poly(ADP-Ribose) Polymerase (PARP1) in vivo using a non-invasive PARP1 PET tracer. Invited. ESMO. Paris, FR.
2022. Radiotherapy advances in gynecology malignancies. Invited. Medical Women’s International Association, US.
2019. A Novel PARPi PET Imaging Tracer. Invited. PARP Conference. Budapest, HU.
2018. Invited Speaker, Controversies in the management of endometrial cancer. Invited. Taiwanese American Radiation Oncology Association, TW.
2018. Invited Speaker, Approach to difficult cases in gynecologic cancer: panel. Invited. Taiwanese American Radiation Oncology Association, TW.
2018. Invited Speaker, Image guided radiotherapy for cervical cancer. Invited. Taiwanese American Radiation Oncology Association, TW.
2016. Invited Speaker, A novel PARPi PET tracer for ovarian carcinoma. Invited. 4th International Conference on Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging and Therapeutic Targets. Rhodes, US.
2012. Metformin use is associated with improved disease free survival in patients with endometrioid adenocarcinoma. Conference. International Gynecologic Cancer Society Annual Meeting Educational Session. Vancouver, US.

Formal Peers

2024. Minding the gap: Improving equity and access to radiation therapy for cervical cancer. Invited. Washington University School of Medicine. St. Louis, MO, US.
2022. MR-Linac Unity for GYN malignancies: MD Anderson experience. Invited. Elekta. Houston, TX, US.
2021. Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin. Invited. Seoul National University Hospital, Korea, US.
2021. Beyond cisplatin for gyn malignancies: combining novel agents and advanced technologies to improve the therapeutic ratio. Visiting. Washington University in St. Louis School of Medicine, MO, US.
2021. Combining novel agents with radiotherapy: beyond the era of cisplatin. Invited. National Cancer Institute, US.
2019. Imaging PARP activity using a novel PARPi PET tracer. Visiting. Columbia University. New York, NY, US.
2018. Imaging PARP activity using a novel PARPi PET tracer. Visiting. MD Anderson Cancer Center. Houston, TX, US.
2017. Visiting Professor, Image guided brachytherapy for cervical cancer. Visiting. Baylor School of Medicine. Houston, TX, US.
2016. Visiting Professor, Collecting patient reported outcomes in clinical trials. Visiting. 2016 Pacific NW annual workshop on methods in radiation oncology clinical course. Portland, OR, US.
2016. Management of cervical and endometrial cancers. Visiting. National Cancer Institute. Bethesda, MD, US.
2015. Imaging of Gynecologic Cancers: Focus on Treatment Planning, Oncologic Imaging: Optimizing Patient Care. Visiting. University of Pennsylvania. Philadelphia, PA, US.
2015. AJCC Staging, Standard of care therapy, Breast and Gynecologic Malignancies, Oncologic Imaging: Optimizing Patient Care. Visiting. University of Pennsylvania. Philadelphia, PA, US.
2015. Mentoring and Career Development Course. Visiting. University of Botswana. Gabarone, US.
2015. Updates in management of gynecologic cancers. Visiting. National Cancer Institute. Bethesda, MD, US.
2014. Proton therapy for breast cancer. Visiting. National Cancer Center. Singapore, US.
2014. Updates in Breast Cancer: Past, Present, Future. Visiting. Society of Nuclear Medicine Annual Meeting. St. Louis, MO, US.
2014. Proton clinical trial development. Visiting. National Cancer Center. Singapore, US.
2014. Proton therapy for gynecologic cancers. Visiting. National Cancer Center. Singapore, US.
2013. Proton Therapy for Gynecologic Cancers. Visiting. IBA/Oncolink. Philadelphia, PA, US.
2013. Radiation Emergencies. Visiting. Princess Marina Hospital. Gabarone, US.
2013. AJCC staging standard of care therapy, and breast and gynecologic malignancies. Visiting. University of Pennsylvania. Philadelphia, PA, US.
2013. HIV and cervical cancer: Building capacity in Botswana. Visiting. University of California - San Francisco. San Francisco, CA, US.
2013. 3D Conformal radiotherapy for gynecologic cancers. Visiting. University of California - San Francisco. San Francisco, CA, US.
2013. Partial breast irradiation. Visiting. Phoenixville Hospital Breast Tumor Board. Phoenixville, PA, US.
2013. Updates in gynecologic malignancies. Visiting. University of Iowa. Iowa City, IA, US.
2013. Beyond the pear: Updates in the management of cervical cancer treatment. Visiting. University of Texas - San Antonio. San Antonio, TX, US.
2013. Updates on cervical cancer management. Visiting. University of California Los Angeles. Los Angeles, CA, US.
2013. Brachytherapy workshop, 1 week course reviewing all aspects of high dose rate gynecologic brachytherapy including implantation, dosimetry, nursing care issues. Invited. Gabarone Private Hospital. Gabarone, Botswana, US.
2013. Image-guided brachytherapy for cervical cancer. Visiting. National Cancer Institute. Bethesda, MD, US.
2013. Vaginal carcinoma. Visiting. Botswana-Harvard partnership. Gabarone, US.
2013. Regional nodal irradiation for locally advanced breast cancer. Visiting. Gaborone Private Hospital. Gabarone, US.
2013. Imaging biomarkers for radiotherapy, center for Magnetic Resonance and Optical Imaging Workshop on Imaging Biomarkers. Invited. University of Pennsylvania. Philadelphia, PA, US.
2013. Imaging of gynecologic cancers: Focus on treatment planning, Oncologic Imaging Symposium. Invited. University of Pennsylvania Department of Radiology. Philadelphia, PA, US.
2012. Advances in the management of cervical cancer. Visiting. Columbia University. New York, NY, US.
2012. Image guided brachytherapy for gynecologic cancers. Visiting. Oregon Health and Science University. Portland, OR, US.
2010. Locoregional Therapies: Radiation Oncology, 2010 Update in Breast Cancer. Visiting. American Society of Clinical Oncology Annual Meeting. Philadelphia, PA, US.
2009. Radiation Oncology 101. Visiting. Abramson Cancer Center's 9th Focus on Gynecologic Cancers Conference. Philadelphia, PA, US.
2008. Hypoxic Imaging Research: A faith based initiative. Visiting. The Eli Glatstein, MD Transnational Research Conference: New Paradigms in Radiation Oncology. Philadelphia, PA, US.
2008. Cervical Cancer: New Directions. Visiting. Grand Rounds. Philadelphia, PA, US.
2008. Imaging for gynecologic malignancies. Visiting. University of Pennsylvania Perelman School of Medicine. Philadelphia, PA, US.
2008. Radiotherapy for Gynecologic Cancers. Visiting. Abramson Cancer Center's 8th Annual Focus on Gynecologic Cancers Conference. Philadelphia, PA, US.
2006. Gynecologic Cancers: 101. Visiting. Abramson Cancer Center's 7th annual Focus on Gynecologic Cancers Conference. Philadelphia, PA, US.
2006. Locally advanced vulvar cancer. Visiting. Walter Reed Army Medical Center. Bethesda, MD, US.

Less

Grant & Contract Support

Title:	The Impact of Biological Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
Funding Source:	NIH/NCI
Role:	PI

Title:	AIDS Malignancy Consortium (AMC)
Funding Source:	NIH/NCI
Role:	Co-PI

Title:	The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Development of a PRO implementation toolkit for radiation oncology
Funding Source:	Pfizer Global Medical Grants
Role:	Co-I

Title:	Clinical outcomes of women with cervical cancer in Zambia
Funding Source:	Varian Medical Systems
Role:	PI

Title:	Serial Imaging of the Novel Radiotracer 18F Fluorthanatrace (18F, FTT) by PET/CT
Funding Source:	Astra Zeneca
Role:	PI

Title:	(PQ3) Addressing Cancer Treatment Disparities for Persons with HIV
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization
Funding Source:	NIH/NCI
Role:	Co-PI

Title:	A novel PARP inhibitor PET tracer for breast cancer
Funding Source:	NIH/NCI
Role:	PI

Title:	Phase I study of talazoparib and radiotherapy for relapsed gyn cancers
Funding Source:	Pfizer
Role:	PI

Title:	Pilot Project 1: A Comprehensive Approach to Inform the Use of Digital Technology for Improving Cervical Cancer Outcomes in Puerto Rico
Funding Source:	NIH
Role:	Co-I

Title:	Phase I Study of Nelfinavir Combined with Chemoradiotherapy for Locally Advanced Vulvar Cancer
Funding Source:	Mike Hogg Foundation
Role:	PI

Title:	Dynamic Targeting using MR guidance for Precision Radiotherapy
Funding Source:	ROSI Shark Tank Award The goal of this study is to demonstrate the clinical impact of personalized radiotherapy using dynamic MR targeting and motion management
Role:	PI

Title:	F18 FAZA PET/MR to interrogate the tumor microenvironment
Funding Source:	Rad Onc Seed Grant Award
Role:	PI

Title:	A Phase I Trial of the Safety and Feasibility of Combined Immune Checkpoint Blockade with Stereotactic Ablative Radiotherapy, SABR, in Metastatic Cervical Cancer
Funding Source:	AstraZeneca
Role:	PI

Title:	Use of a novel PARP inhibitor PET tracer in patients with relapsed ovarian carcinoma
Funding Source:	MDACC
Role:	PI

Title:	Checkpoint inhibition combined with radiotherapy for metastatic uterine carcinoma
Funding Source:	M.D. Anderson Gynecologic SPORE for Uterine Cancers
Role:	PI

Title:	Pilot study of a novel PARP inhibitor PET tracer in patients with ovarian carcinoma
Funding Source:	Kaleidoscope of Hope Ovarian Cancer Foundation
Role:	PI

Title:	Pilot study of a novel PARP inhibitor PET tracer in patients with ovarian carcinoma
Funding Source:	Marsha Rivkin Ovarian Cancer Foundation
Role:	PI

Title:	Integrated electronic capture of patient reported outcomes, Varian Medical Systems
Funding Source:	Varian Medical Systems
Role:	PI

Title:	Development and piloting of a novel PARP inhibitor PET tracer
Funding Source:	ITMAT
Role:	Primary Investigator

Title:	Investigation of the Effects of Nelfinavir and Chemoradiation on Signaling Pathways, Hypoxia and Immune Modulation in a Phase I Trial for Locally Advanced Cervical Cancer
Funding Source:	Abramson Cancer Center, Department of Radiation Oncology
Role:	Co-I

Title:	Cardiotoxicity of Radiation Therapy
Funding Source:	Abramson Cancer Center, Department of Radiation Oncology
Role:	Co-PI

Title:	Measurement of PARP - 1 Activation with the PET Radiotracer [18F] WC-138: In vitro Validation Studies
Funding Source:	Abramson Cancer Center
Role:	Collaborator

Title:	Botswana-U-Penn: Research Consortium of HPV-related Cervical Cancer in HIV Patients, NIH, U54
Funding Source:	Botswana-U-Penn
Role:	Project Leader

Title:	FLT/PET/CT imaging for bone marrow sparing radiotherapy
Funding Source:	Department of Radiation Oncology
Role:	PI

Title:	Immune reconstitution as a maneuver to improve tumor response to definitive chemoradiotherapy in HIV+ patients with cervical cancer
Funding Source:	Penn Center for AIDS Research
Role:	Co-PI

Title:	Impact of HIV infection and treatment on tolerability of cervical cancer therapy in Botswana
Funding Source:	Penn Center for AIDS Research
Role:	Co-PI

Title:	F18 EF5 PET/CT Imaging in Patients with Brain Metastases from Breast Cancer
Funding Source:	Department of Defense
Role:	PI

Title:	Reducing Cardiac Morbidity for Women with left sided Breast Cancer: The Potential of Proton Radiotherapy
Funding Source:	Kynett-FOCUS Junior Faculty Investigator Award
Role:	PI

Title:	Feasibility Study of Adherence Intervention for Dilator Use Following Endometrial Cancer, NIH R21, 1-R21-CA140766-01
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Phase I F-18 EF5 Pilot Study
Funding Source:	Varian Biosynergy
Role:	Co-I

Title:	A pilot study of [F18]EF5 PET/CT hypoxia imaging for patients with locally advanced cervical carcinoma receiving chemoradiotherapy
Funding Source:	McCabe Award
Role:	PI

Title:	Digital health to improve outcomes in women with cervical cancer
Funding Source:	NIH/NCI
Role:	Co-I

Title:	Identification of immunologic determinants of mortality and recurrence in women with cervical cancer in Zambia
Funding Source:	NIH/NCI
Role:	PI

CV information above last modified January 24, 2025

Lilie L. Lin, MD, FASTRO

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Other Articles

Abstracts

Book Chapters

Books (edited and written)

Selected Presentations & Talks

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Lilie L. Lin, MD, FASTRO

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Other Articles

Abstracts

Book Chapters

Books (edited and written)

Selected Presentations & Talks

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer